All cancer survivors, families, friends and health care providers are invited to The University of Michigan Comprehensive Caner Center’s Survivors Day Celebration on June 4.
Study available at U-M evaluates reparixin in combination with paclitaxel for metastatic triple-negative breast cancer
Triple-negative is the most aggressive kind of breast cancer. Triple negative tumors are negative for estrogen receptor, progesterone receptor and the HER2 protein. Because treatments that target these proteins would not work in triple negative breast cancer, the main treatment for it is chemotherapy.
In a randomized clinical trial conducted by researchers at University of Southampton, biliary cancer patients treated with capecitabine as adjuvant therapy lived, on average, more than a year longer than those who were only observed, according to a post in HemOnc Today.
The Daily Mail reports that a new study, released in advance of the upcoming American Society of Clinical Oncology annual meeting, links the regular consumption of tree nuts such as almonds, cashews and Brazil nuts, to better outcomes for colon cancer patients.
The number of people diagnosed with thyroid cancer is increasing -- one of the few cancers for which this is still the case. But a subset of these patients may be getting overdiagnosed with cancer.
In work that could improve understanding of how cancer spreads, a team of engineers and medical researchers at the University of Michigan developed a new kind of microfluidic chip that can capture rare, aggressive cancer cells, grow them on the chip and release single cells on demand.
Researchers at Michigan Medicine have found a protein that stops cancer’s ability to prevent the immune system from destroying cancer cells. The protein is called free C3d, and it has the potential to be developed into a cancer vaccine and a cancer treatment.
Can your phone make you healthier? That’s what researchers at the University of Michigan are hoping to find out.
U of M Faculty Identifies Clustering of Esophageal Cancer Mortality in the Great Lakes States and New England
Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Despite the rates of some cancers falling over the past 25 years, the frequency of some esophageal cancers is growing and physicians are unable to explain why.
New, statistically derived guidelines are helping urologists across Michigan zero in on which prostate cancer patients to scan for spread of their disease.